Nicholas M. P. King

11.5k total citations · 2 hit papers
168 papers, 8.8k citations indexed

About

Nicholas M. P. King is a scholar working on Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Nicholas M. P. King has authored 168 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 34 papers in Psychiatry and Mental health and 31 papers in Molecular Biology. Recurrent topics in Nicholas M. P. King's work include Epilepsy research and treatment (28 papers), Analytical Methods in Pharmaceuticals (22 papers) and Pharmacogenetics and Drug Metabolism (21 papers). Nicholas M. P. King is often cited by papers focused on Epilepsy research and treatment (28 papers), Analytical Methods in Pharmaceuticals (22 papers) and Pharmacogenetics and Drug Metabolism (21 papers). Nicholas M. P. King collaborates with scholars based in United States, Germany and Australia. Nicholas M. P. King's co-authors include David J. Greenblatt, Richard I. Shader, Janice B. Schwartz, Marcia Divoll, Michael J. Hanley, Jerold S. Harmatz, Ann Locniskar, Nikolai M. Soldatov, James T. Cross and Hui C. Kimko and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Nicholas M. P. King

163 papers receiving 8.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Obesity on the Pharmacokinetics of Drugs in Humans

2010 557 citations Nicholas M. P. King, David J. Greenblatt et al. profile →
Effect of Age, Gender, and Obesity on Midazolam Kinetics

1984 402 citations David J. Greenblatt, Nicholas M. P. King et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas M. P. King United States	53	1.8k	1.5k	1.2k	1.2k	1.1k	168	8.8k
David G. Shand United States	53	2.8k 1.6×	1.6k 1.1×	2.2k 1.8×	2.1k 1.8×	962 0.9×	150	10.6k
Jürgen Drewe Switzerland	65	1.1k 0.6×	3.0k 2.0×	989 0.8×	1.1k 1.0×	1.5k 1.4×	306	15.3k
Jean‐Louis Montastruc France	51	1.1k 0.6×	850 0.6×	431 0.4×	1.0k 0.9×	1.4k 1.2×	458	10.5k
Wilhelm Kirch Germany	46	1.8k 1.0×	906 0.6×	794 0.7×	1.1k 0.9×	805 0.7×	381	8.5k
Jan Koch‐Weser United States	76	4.1k 2.3×	3.0k 2.0×	1.2k 1.0×	2.3k 2.0×	1.5k 1.3×	220	15.4k
Jules Desmeules Switzerland	42	538 0.3×	774 0.5×	1.9k 1.5×	1.3k 1.1×	956 0.9×	240	6.4k
Alan S. Nies United States	53	2.4k 1.4×	1.4k 0.9×	888 0.7×	1.8k 1.6×	395 0.4×	170	7.9k
Evan D. Kharasch United States	61	961 0.5×	1.9k 1.3×	3.4k 2.8×	1.4k 1.2×	2.0k 1.8×	298	12.1k
Pierre Dayer Switzerland	55	547 0.3×	1.8k 1.2×	3.2k 2.7×	1.6k 1.4×	1.2k 1.0×	202	8.8k
Jerold S. Harmatz United States	65	680 0.4×	983 0.7×	4.0k 3.3×	2.4k 2.1×	1.7k 1.5×	236	11.8k

Countries citing papers authored by Nicholas M. P. King

Since Specialization

Citations

This map shows the geographic impact of Nicholas M. P. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas M. P. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas M. P. King more than expected).

Fields of papers citing papers by Nicholas M. P. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas M. P. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas M. P. King. The network helps show where Nicholas M. P. King may publish in the future.

Co-authorship network of co-authors of Nicholas M. P. King

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas M. P. King. A scholar is included among the top collaborators of Nicholas M. P. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas M. P. King. Nicholas M. P. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sarntivijai, Sirarat, Shadia Zaman, Keith Burkhart, et al.. (2016). Linking MedDRA®-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors. Drug Safety. 39(7). 697–707. 21 indexed citations

Curtis, Michael J. & Nicholas M. P. King. (2014). Advice on statistical analysis, and new journal guidance for experimental design and analysis. Pharmacology Research & Perspectives. 3(1). e00095–e00095. 5 indexed citations

Huang, Shiew-Mei, Nicholas M. P. King, Yaning Wang, Ping Zhao, & Issam Zineh. (2013). The Utility of Modeling and Simulation in Drug Development and Regulatory Review. Journal of Pharmaceutical Sciences. 102(9). 2912–2923. 160 indexed citations

Bai, Jane P. F. & Nicholas M. P. King. (2012). Systems Pharmacology to Predict Drug Toxicity: Integration Across Levels of Biological Organization. The Annual Review of Pharmacology and Toxicology. 53(1). 451–473. 96 indexed citations

Moore, Jeffrey C., Jonathan W DeVries, Markus Lipp, James C. Griffiths, & Nicholas M. P. King. (2010). Total Protein Methods and Their Potential Utility to Reduce the Risk of Food Protein Adulteration. Comprehensive Reviews in Food Science and Food Safety. 9(4). 330–357. 179 indexed citations

Gnjidic, Danijela, Robert G. Cumming, David G. Le Couteur, et al.. (2009). Drug Burden Index and physical function in older Australian men. British Journal of Clinical Pharmacology. 68(1). 97–105. 129 indexed citations

Morris, Tina S., et al.. (2009). Heparin monographs further revised. 33(3). 136–137. 1 indexed citations

Cecil, Todd L., et al.. (2008). The US Pharmacopeia near Infrared System Suitability Reference Standard. Journal of Near Infrared Spectroscopy. 16(3). 205–210. 1 indexed citations

Mager, Donald E., et al.. (2007). Analysis of Functional Signaling Domains from Fluorescence Imaging and the Two-Dimensional Continuous Wavelet Transform. Biophysical Journal. 93(8). 2900–2910. 10 indexed citations

10.

Agostini, Joseph V., Sarah N. Hilmer, Ronald I. Shorr, et al.. (2007). a drug burden index to define the functional burden of medications in older people. Commentary : A step forward. JAMA Internal Medicine. 167(8). 1 indexed citations

11.

Kobrinsky, Evgeny, et al.. (2005). Identification of Plasma Membrane Macro- and Microdomains from Wavelet Analysis of FRET Microscopy. Biophysical Journal. 88(5). 3625–3634. 8 indexed citations

12.

Kobrinsky, Evgeny, Alexander Yu, Jo Beth Harry, et al.. (2004). Voltage-Gated Rearrangements Associated with Differential β-Subunit Modulation of the L-Type Ca2+ Channel Inactivation. Biophysical Journal. 87(2). 844–857. 26 indexed citations

13.

Mager, Donald E., Mary Ann Mascelli, Neal S. Kleiman, Desmond J. Fitzgerald, & Nicholas M. P. King. (2003). Simultaneous Modeling of Abciximab Plasma Concentrations and ex Vivo Pharmacodynamics in Patients Undergoing Coronary Angioplasty. Journal of Pharmacology and Experimental Therapeutics. 307(3). 969–976. 36 indexed citations

14.

Trapnell, Carol Braun, Stephen Donahue, Jerry M. Collins, et al.. (1998). Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone*. Clinical Pharmacology & Therapeutics. 64(6). 597–602. 22 indexed citations

15.

Hayes, W S, John J. Pahira, Nicholas M. P. King, et al.. (1996). <title>Technology assessment for an integrated PC-based platform for three telemedicine applications</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2711. 335–344. 2 indexed citations

16.

King, Nicholas M. P., Joseph C. Alper, Michael C. Wiemann, Charles J. McDonald, & Paul Calabresi. (1989). Oral 5-Fluorouracil in Psoriasis: Pharmacokinetic-Pharmacodynamic Relationships. Pharmacology. 39(2). 78–88. 16 indexed citations

17.

Greenblatt, David J., Nicholas M. P. King, Marcia Divoll, et al.. (1984). Noninteraction of Temazepam and Cimetidine. Journal of Pharmaceutical Sciences. 73(3). 399–401. 13 indexed citations

18.

Greenblatt, David J., Marcia Divoll, Nicholas M. P. King, Ann Locniskar, & Richard I. Shader. (1983). Pharmacokinetics of Benzodiazepine Hypnotics. Pharmacology. 27(2). 70–75. 24 indexed citations

19.

Greenblatt, David J., Nicholas M. P. King, Marcia Divoll, Hermann R. Ochs, & Richard I. Shader. (1983). Antipyretic analgesic drugs as models for studies of drug disposition in old age. The American Journal of Medicine. 75(5). 127–132. 3 indexed citations

20.

King, Nicholas M. P. & Daniel L. Azarnoff. (1977). Effect of drugs which alter microsomal drug-metabolizing enzyme activity on rat hepatic cholesterol biosynthesis. Biochemical Pharmacology. 26(6). 481–484. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact